ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 679005 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 679005; 2) Community: the network communities that were significantly associated with the response to NSC 679005; 3) Molecule: the relationships between components within communities and NSC 679005; 4) MDR: the compounds that were significantly associated with the NSC 679005.

NSC Compound Enrichment Correlation
NSC 641052 Platinum, dichloro[(phenylmethyl)methylsulfinyl]- 1-quinolinyl-, (SP-4-1) 0.0385203205529756 0.79919061
NSC 644474 Null 0.0385203205529756 0.043385091
NSC 722219 (+-)-2,2-Dimethylpropionic acid (Z)-{2-(hydroxymethyl)-4-[5- methyl-3-(2-methylpropyl)hexylidene]-5-oxo(2-2,3-dihydrofuryl)} methyl ester 0.0385203205529759 0.054629264
NSC 100880 Camptothecin 0.0396077140933377 0.11625246
NSC 113497 16,17-Seco-24-nor-5.alpha.,13.alpha.,14.beta.,17.alpha.-chola-1,20,22-trien-16-oic acid, 14,15.beta.:21,23-diepoxy-7.alpha.,17-dihydroxy-4,4,8-trimethyl-3-oxo-, 16,17-lactone, acetate (8CI) 0.0396077140933377 0.1688964
NSC 13151 Null 0.0396077140933377 0.27763145
NSC 244404 Null 0.0396077140933377 0.29297083
NSC 300289 Pinafide 0.0396077140933377 0.26640889
NSC 303861 L-Cysteine analog 0.0396077140933377 0.60218412
NSC 328410 Camptothecin Derivative 0.0396077140933377 0.094742989
Total:117  Current:101    [First] [Prev] [Next] [Last]